Conference attendance and presentations

IXICO plc

("IXICO" or the "Company")

Conference attendance and presentations

IXICO virtually attends AD/PD 2021 Conference

IXICO plc (AIM: IXI), the AI data analytics company delivering insights in neuroscience, announces it will be presenting at the upcoming virtual AD/PD 2021 conference taking place virtually on 9-14 March 2021. AD/PD 2021, the 15th International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders, is one of the most prestigious in the year and IXICO welcomes the opportunity to present.

The following presentation and poster presentations will be made across the week:

·    Michael Reinwald, PhD, Associate Research Engineer at IXICO plc, will give a pre-recorded oral presentation, titled: "A deep-learning based framework for brain-atrophy measurement"

·    Jack Weatheritt, PhD, Senior Research Engineer at IXICO plc, will present the poster: "Automatic segmentation using deep learning for the hippocampus"

·    Luis Peraza, PhD, Research Engineer at IXICO plc, will present two posters:

1) "An adaptive step detection algorithm for waist-worn wearable devices: a feasibility study in older adults"

2) "Added value of wearable sensors for fall risk assessment in an older adult group"

The conference attracts international medical and scientific professionals worldwide to focus on the mechanisms of disease, prevention and therapy within the neurodegenerative disease space. More information on the conference can be found here: Welcome Message - AD/PD™ 2021 | March 9 - 14, 2021 | Virtual Conference (kenes.com)

Robin Wolz, Chief Scientific Officer at IXICO, commented: "We are excited about the opportunity to provide an update on various R&D activities at the AD/PD conference. Deep learning approaches in combination with well curated, high-quality data enable us to develop tools that can extract clinically meaningful insights that were previously not detectable and at a processing speed previously unthinkable. We look forward to sharing an update on how this technology impacts our ability to interpret both imaging and wearables data."

The video presentation and related posters will be available on the Company's website after the event has concluded, here: Webinars » IXICO and Publications » IXICO.

For further information please contact:

About IXICO

IXICO is dedicated to delivering insights in neuroscience. Our purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights in neuroscience and our goal is to be a leading proponent of artificial intelligence in medical image analysis. We will achieve this by developing and deploying breakthrough data analytics, at scale, through our remote access technology platform, to improve the return on investment in drug development and reduce risk and uncertainty in clinical trials for our pharmaceutical clients.

More information is available on www.IXICO.com and follow us on Twitter @IxicOplc